Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Mar;64(Suppl 2):ii26–ii29. doi: 10.1136/ard.2004.031740

Immunopathology of psoriasis and psoriatic arthritis

D Veale, C Ritchlin, O FitzGerald
PMCID: PMC1766860  PMID: 15708930

Abstract

Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate it from rheumatoid arthritis (RA). Attempts to identify immunopathological mechanisms, some shared with psoriasis, that underlie these differences from RA have been most challenging. Recent research studies, however, highlight novel findings in PsA at the molecular, cellular, and tissue levels that form the basis for a new understanding of this relatively common form of inflammatory arthritis. In particular, the availability of new, biological antitumour necrosis factor α therapies have allowed further insight into the immunopathology of psoriasis and PsA. This brief review focuses on immunohistological studies in psoriatic skin, PsA synovium, and bone to demonstrate how these data advance our knowledge of disease pathogenesis.

Full Text

The Full Text of this article is available as a PDF (109.4 KB).

Figure 1.

Figure 1

Open in a new tab

 Immunohistochemical staining of tumour necrosis factor α protein in a section of psoriatic synovial membrane.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoni Christian, Dechant Claudia, Hanns-Martin Lorenz P. D., Wendler Joerg, Ogilvie Alexandra, Lueftl Mathias, Kalden-Nemeth Dolores, Kalden Joachim R., Manger Bernhard. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum. 2002 Oct 15;47(5):506–512. doi: 10.1002/art.10671. [DOI] [PubMed] [Google Scholar]
  2. Asumalahti K., Laitinen T., Itkonen-Vatjus R., Lokki M. L., Suomela S., Snellman E., Saarialho-Kere U., Kere J. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum Mol Genet. 2000 Jun 12;9(10):1533–1542. doi: 10.1093/hmg/9.10.1533. [DOI] [PubMed] [Google Scholar]
  3. Balding Joanna, Kane David, Livingstone Wendy, Mynett-Johnson Lesley, Bresnihan Barry, Smith Owen, FitzGerald Oliver. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 2003 May;48(5):1408–1413. doi: 10.1002/art.10935. [DOI] [PubMed] [Google Scholar]
  4. Bengtsson Asa K., Ryan Elizabeth J. Immune function of the decoy receptor osteoprotegerin. Crit Rev Immunol. 2002;22(3):201–215. [PubMed] [Google Scholar]
  5. Bhushan M., Moore T., Herrick A. L., Griffiths C. E. Nailfold video capillaroscopy in psoriasis. Br J Dermatol. 2000 Jun;142(6):1171–1176. doi: 10.1046/j.1365-2133.2000.03544.x. [DOI] [PubMed] [Google Scholar]
  6. Boyle William J., Simonet W. Scott, Lacey David L. Osteoclast differentiation and activation. Nature. 2003 May 15;423(6937):337–342. doi: 10.1038/nature01658. [DOI] [PubMed] [Google Scholar]
  7. Braverman I. M., Yen A. Microcirculation in psoriatic skin. J Invest Dermatol. 1974 May;62(5):493–502. doi: 10.1111/1523-1747.ep12681007. [DOI] [PubMed] [Google Scholar]
  8. Braverman I. M., Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol. 1977 Jan;68(1):53–60. doi: 10.1111/1523-1747.ep12485169. [DOI] [PubMed] [Google Scholar]
  9. Chang J. C., Smith L. R., Froning K. J., Schwabe B. J., Laxer J. A., Caralli L. L., Kurland H. H., Karasek M. A., Wilkinson D. I., Carlo D. J. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9282–9286. doi: 10.1073/pnas.91.20.9282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chaudhari U., Romano P., Mulcahy L. D., Dooley L. T., Baker D. G., Gottlieb A. B. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 2001 Jun 9;357(9271):1842–1847. doi: 10.1016/s0140-6736(00)04954-0. [DOI] [PubMed] [Google Scholar]
  11. Costello P. J., Winchester R. J., Curran S. A., Peterson K. S., Kane D. J., Bresnihan B., FitzGerald O. M. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol. 2001 Feb 15;166(4):2878–2886. doi: 10.4049/jimmunol.166.4.2878. [DOI] [PubMed] [Google Scholar]
  12. Costello P., Bresnihan B., O'Farrelly C., FitzGerald O. Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol. 1999 May;26(5):1117–1124. [PubMed] [Google Scholar]
  13. Creamer D., Jaggar R., Allen M., Bicknell R., Barker J. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol. 1997 Dec;137(6):851–855. [PubMed] [Google Scholar]
  14. Creamer D., Sullivan D., Bicknell R., Barker J. Angiogenesis in psoriasis. Angiogenesis. 2002;5(4):231–236. doi: 10.1023/a:1024515517623. [DOI] [PubMed] [Google Scholar]
  15. Curran Shane A., FitzGerald Oliver M., Costello Patrick J., Selby Jeanette M., Kane David J., Bresnihan Barry, Winchester Robert. Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol. 2004 Feb 1;172(3):1935–1944. doi: 10.4049/jimmunol.172.3.1935. [DOI] [PubMed] [Google Scholar]
  16. Danning C. L., Illei G. G., Hitchon C., Greer M. R., Boumpas D. T., McInnes I. B. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 2000 Jun;43(6):1244–1256. doi: 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  17. Eedy D. J., Johnston C. F., Shaw C., Buchanan K. D. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol. 1991 Apr;96(4):434–438. doi: 10.1111/1523-1747.ep12469898. [DOI] [PubMed] [Google Scholar]
  18. Fearon U., Reece R., Smith J., Emery P., Veale D. J. Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci. 1999 Jun 30;878:619–621. doi: 10.1111/j.1749-6632.1999.tb07743.x. [DOI] [PubMed] [Google Scholar]
  19. Fearon U., Veale D. J. Pathogenesis of psoriatic arthritis. Clin Exp Dermatol. 2001 Jun;26(4):333–337. doi: 10.1046/j.1365-2230.2001.00792.x. [DOI] [PubMed] [Google Scholar]
  20. Fearon Ursula, Griosios Konstantina, Fraser Alexander, Reece Richard, Emery Paul, Jones Pamela F., Veale Douglas J. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol. 2003 Feb;30(2):260–268. [PubMed] [Google Scholar]
  21. Fraser Alexander, Fearon Ursula, Billinghurst R. Clark, Ionescu Mirela, Reece Richard, Barwick Thomas, Emery Paul, Poole A. Robin, Veale Douglas J. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum. 2003 Nov;48(11):3085–3095. doi: 10.1002/art.11331. [DOI] [PubMed] [Google Scholar]
  22. Gladman D. D., Anhorn K. A., Schachter R. K., Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol. 1986 Jun;13(3):586–592. [PubMed] [Google Scholar]
  23. Gonzalez S., Martinez-Borra J., Del Río J. S., Santos-Juanes J., Lopez-Vazquez A., Blanco-Gelaz M., López-Larrea C. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol. 2000 Nov;115(5):824–828. doi: 10.1046/j.1523-1747.2000.00133.x. [DOI] [PubMed] [Google Scholar]
  24. Gottlieb Alice B., Matheson Robert T., Lowe Nicholas, Krueger Gerald G., Kang Sewon, Goffe Bernard S., Gaspari Anthony A., Ling Mark, Weinstein Gerald D., Nayak Anjuli. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol. 2003 Dec;139(12):1627–1632. doi: 10.1001/archderm.139.12.1627. [DOI] [PubMed] [Google Scholar]
  25. Gottlieb S. L., Gilleaudeau P., Johnson R., Estes L., Woodworth T. G., Gottlieb A. B., Krueger J. G. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1995 May;1(5):442–447. doi: 10.1038/nm0595-442. [DOI] [PubMed] [Google Scholar]
  26. Gravallese E. M. Bone destruction in arthritis. Ann Rheum Dis. 2002 Nov;61 (Suppl 2):ii84–ii86. doi: 10.1136/ard.61.suppl_2.ii84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gravallese E. M., Manning C., Tsay A., Naito A., Pan C., Amento E., Goldring S. R. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000 Feb;43(2):250–258. doi: 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  28. Kane David, FitzGerald Oliver. Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective. Curr Rheumatol Rep. 2004 Aug;6(4):292–298. doi: 10.1007/s11926-004-0041-0. [DOI] [PubMed] [Google Scholar]
  29. Kane David, Roth Johannes, Frosch Michael, Vogl Thomas, Bresnihan Barry, FitzGerald Oliver. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum. 2003 Jun;48(6):1676–1685. doi: 10.1002/art.10988. [DOI] [PubMed] [Google Scholar]
  30. Kupper Thomas S. Immunologic targets in psoriasis. N Engl J Med. 2003 Nov 20;349(21):1987–1990. doi: 10.1056/NEJMp038164. [DOI] [PubMed] [Google Scholar]
  31. Kuroda K., Sapadin A., Shoji T., Fleischmajer R., Lebwohl M. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol. 2001 May;116(5):713–720. doi: 10.1046/j.1523-1747.2001.01316.x. [DOI] [PubMed] [Google Scholar]
  32. Laloux L., Voisin M. C., Allain J., Martin N., Kerboull L., Chevalier X., Claudepierre P. Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 2001 Apr;60(4):316–321. doi: 10.1136/ard.60.4.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lam J., Takeshita S., Barker J. E., Kanagawa O., Ross F. P., Teitelbaum S. L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000 Dec;106(12):1481–1488. doi: 10.1172/JCI11176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Leonardi Craig L., Powers Jerold L., Matheson Robert T., Goffe Bernard S., Zitnik Ralph, Wang Andrea, Gottlieb Alice B., Etanercept Psoriasis Study Group Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003 Nov 20;349(21):2014–2022. doi: 10.1056/NEJMoa030409. [DOI] [PubMed] [Google Scholar]
  35. Massey H. M., Flanagan A. M. Human osteoclasts derive from CD14-positive monocytes. Br J Haematol. 1999 Jul;106(1):167–170. doi: 10.1046/j.1365-2141.1999.01491.x. [DOI] [PubMed] [Google Scholar]
  36. Mease P. J., Goffe B. S., Metz J., VanderStoep A., Finck B., Burge D. J. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000 Jul 29;356(9227):385–390. doi: 10.1016/S0140-6736(00)02530-7. [DOI] [PubMed] [Google Scholar]
  37. Mease Philip J. Current treatment of psoriatic arthritis. Rheum Dis Clin North Am. 2003 Aug;29(3):495–511. doi: 10.1016/s0889-857x(03)00047-4. [DOI] [PubMed] [Google Scholar]
  38. Mulherin D., Bresnihan B., FitzGerald O. Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J Rheumatol. 1995 Jun;22(6):1211–1212. [PubMed] [Google Scholar]
  39. Nair R. P., Stuart P., Henseler T., Jenisch S., Chia N. V., Westphal E., Schork N. J., Kim J., Lim H. W., Christophers E. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000 May 5;66(6):1833–1844. doi: 10.1086/302932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nickoloff B. J., Bonish B., Huang B. B., Porcelli S. A. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci. 2000 Dec;24(3):212–225. doi: 10.1016/s0923-1811(00)00120-1. [DOI] [PubMed] [Google Scholar]
  41. Paukkonen K., Naukkarinen A., Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8 + T cells and CD11c + macrophages into the epidermis. Arch Dermatol Res. 1992;284(7):375–379. doi: 10.1007/BF00372065. [DOI] [PubMed] [Google Scholar]
  42. Peng Hairong, Wright Vonda, Usas Arvydas, Gearhart Brian, Shen Hsain-Chung, Cummins James, Huard Johnny. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002 Sep;110(6):751–759. doi: 10.1172/JCI15153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pitzalis C., Cauli A., Pipitone N., Smith C., Barker J., Marchesoni A., Yanni G., Panayi G. S. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum. 1996 Jan;39(1):137–145. doi: 10.1002/art.1780390118. [DOI] [PubMed] [Google Scholar]
  44. Reece R. J., Canete J. D., Parsons W. J., Emery P., Veale D. J. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum. 1999 Jul;42(7):1481–1484. doi: 10.1002/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  45. Ridge J. P., Di Rosa F., Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998 Jun 4;393(6684):474–478. doi: 10.1038/30989. [DOI] [PubMed] [Google Scholar]
  46. Ritchlin C., Haas-Smith S. A., Hicks D., Cappuccio J., Osterland C. K., Looney R. J. Patterns of cytokine production in psoriatic synovium. J Rheumatol. 1998 Aug;25(8):1544–1552. [PubMed] [Google Scholar]
  47. Ritchlin Christopher T., Haas-Smith Sally A., Li Ping, Hicks David G., Schwarz Edward M. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003 Mar;111(6):821–831. doi: 10.1172/JCI16069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tassiulas I., Duncan S. R., Centola M., Theofilopoulos A. N., Boumpas D. T. Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol. 1999 Jun;60(6):479–491. doi: 10.1016/s0198-8859(99)00034-8. [DOI] [PubMed] [Google Scholar]
  49. Teitelbaum S. L. Bone resorption by osteoclasts. Science. 2000 Sep 1;289(5484):1504–1508. doi: 10.1126/science.289.5484.1504. [DOI] [PubMed] [Google Scholar]
  50. Valdimarsson H., Baker B. S., Jónsdóttir I., Powles A., Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today. 1995 Mar;16(3):145–149. doi: 10.1016/0167-5699(95)80132-4. [DOI] [PubMed] [Google Scholar]
  51. Veale D. J., Barnes L., Rogers S., FitzGerald O. Immunohistochemical markers for arthritis in psoriasis. Ann Rheum Dis. 1994 Jul;53(7):450–454. doi: 10.1136/ard.53.7.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Veale D., Farrell M., Fitzgerald O. Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol. 1993 May;32(5):413–416. doi: 10.1093/rheumatology/32.5.413. [DOI] [PubMed] [Google Scholar]
  53. Veale D., Rogers S., Fitzgerald O. Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. Br J Dermatol. 1995 Jan;132(1):32–38. doi: 10.1111/j.1365-2133.1995.tb08621.x. [DOI] [PubMed] [Google Scholar]
  54. Veale D., Yanni G., Rogers S., Barnes L., Bresnihan B., Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993 Jul;36(7):893–900. doi: 10.1002/art.1780360705. [DOI] [PubMed] [Google Scholar]
  55. Winchester R., Brancato L., Itescu S., Skovron M. L., Solomon G. Implications from the occurrence of Reiter's syndrome and related disorders in association with advanced HIV infection. Scand J Rheumatol Suppl. 1988;74:89–93. doi: 10.3109/03009748809102943. [DOI] [PubMed] [Google Scholar]
  56. Zaric D., Worm A. M., Stahl D., Clemmensen O. J. Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol. 1981;10(3):249–252. doi: 10.3109/03009748109095307. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES